Thursday, July 9, 2026

pharma · Chronic Diabetic Foot Ulcers · Diabetic Foot Infection · LABT

Lakewood-Amedex Biotherapeutics

Lakewood-Amedex Biotherapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

University Park, USA HQ
8 Employees
Public company Type
LABT · NYSE Ticker
Company details
Status
Public
HQ
University Park, USA
Employees
8
Programs
4
Drugs
1
Patents
18
Intelligence · Drug Pipeline

Lakewood-Amedex Biotherapeutics pipeline

Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Lakewood-Amedex Biotherapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

1 compounds
  1. Development asset linked to Lakewood-Amedex Biotherapeutics in public FDA and regional records.